BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 31432411)

  • 1. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
    Macron C; Núñez Galindo A; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood.
    Dayon L; Núñez Galindo A; Cominetti O; Corthésy J; Kussmann M
    Methods Mol Biol; 2017; 1619():433-449. PubMed ID: 28674902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
    Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
    Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery.
    Núñez Galindo A; Kussmann M; Dayon L
    Anal Chem; 2015 Nov; 87(21):10755-61. PubMed ID: 26452177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
    Macron C; Lane L; Núñez Galindo A; Dayon L
    J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
    Anjo SI; Santa C; Manadas B
    Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Sample Preparation for Data-Independent Acquisition.
    Barkovits K; Tönges L; Marcus K
    Methods Mol Biol; 2019; 2044():61-67. PubMed ID: 31432406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in high-throughput proteomic analysis].
    Wu Q; Sui X; Tian R
    Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
    Gritsenko MA; Xu Z; Liu T; Smith RD
    Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
    Ziganshin RH; Kovalchuk SI; Azarkin IV
    Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of 2D-DIGE and iTRAQ Workflows to Analyze CSF in Gliomas.
    Rao AA; Mehta K; Gahoi N; Srivastava S
    Methods Mol Biol; 2019; 2044():81-110. PubMed ID: 31432408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of Human Milk: Definition of a Discovery Workflow for Clinical Research Studies.
    Dayon L; Macron C; Lahrichi S; Núñez Galindo A; Affolter M
    J Proteome Res; 2021 May; 20(5):2283-2290. PubMed ID: 33769819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using
    Birke R; Krause E; Schümann M; Blasig IE; Haseloff RF
    Methods Mol Biol; 2019; 2044():119-128. PubMed ID: 31432410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
    Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
    Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Profiling of Proteome and Phosphoproteome by Isobaric Labeling, Extensive Liquid Chromatography, and Mass Spectrometry.
    Bai B; Tan H; Pagala VR; High AA; Ichhaporia VP; Hendershot L; Peng J
    Methods Enzymol; 2017; 585():377-395. PubMed ID: 28109439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.